Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Rankning i aktier #2736
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Aktiekurs
$70.50
Senast synkroniserad: 2025-11-14
Marknadsvärde
$7.33B
Förändring (1 dag)
0.00%
Förändring (1 år)
116.32%
Land
US
Handel Metsera, Inc. (MTSR)

Kategori

Aktiekurshistorik för Metsera, Inc. (MTSR)
Högsta slutkurs: $72.34 den 2025-11-01

Lägsta slutkurs: $26.50 den 2025-01-01
Aktiekurshistorik för Metsera, Inc. från 2025 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -29.98%
2025 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$553.23 42.24%
US
$1.02K 50.35%
NL
$157.70 522.09%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH